Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma-Reference-Cited by-同舟云学术

Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma

Published:2022-10 Issue:10 Volume:15 Page:100703
ISSN:1939-4551
Container-title:World Allergy Organization Journal
language:en
Short-container-title:World Allergy Organization Journal

Author:

Bölke Georg^ORCID,Tong Xunliang,Zuberbier Torsten,Bousquet Jean,Bergmann Karl-Christian^ORCID

Publisher

Elsevier BV

Subject

Immunology and Allergy,Immunology,Pulmonary and Respiratory Medicine

Reference21 articles.

1. The prevalence of severe refractory asthma;Hekking;J Allergy Clin Immunol,2015

2. Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective;Jeimy;Allergy Asthma Clin Immunol,2018

3. Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: indirect treatment comparison;Busse;J Allergy Clin Immunol,2019

4. Real-word experience with mepolizumab: does it deliver what it has promised?;Schleich;Clin Exper Allergy,2020

5. Mepolizumab add-on therapy in a real world cohort of patients with severe eosinophilic asthma: response rate, effectiveness, and safety;van Toor;J Asthma,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stepping down biologics in asthma: is it time to challenge the status quo?;European Respiratory Journal;2024-08

2. Clinical Remission Criteria and Serum Levels of Type 2 Inflammation Mediators during 24 Weeks of Treatment with the Anti-IL-5 Drug Mepolizumab in Patients with T2-High Severe Asthma;Diagnostics;2024-06-25

3. Titration of anti-IL-5 biologics in severe asthma: an open-label randomised controlled trial (the OPTIMAL study);European Respiratory Journal;2024-06-06

4. Chronische Rhinosinusitis mit nasalen Polypen – Verlängerung der Dupilumab-Therapieintervalle;HNO;2024-05-18

5. The Saudi initiative for asthma – 2024 update: Guidelines for the diagnosis and management of asthma in adults and children;Annals of Thoracic Medicine;2023-12-15